Literature DB >> 10092850

Molecular cloning of cDNAs of mouse peptidylarginine deiminase type I, type III and type IV, and the expression pattern of type I in mouse.

A A Rus'd1, Y Ikejiri, H Ono, T Yonekawa, M Shiraiwa, A Kawada, H Takahara.   

Abstract

Peptidylarginine deiminases (PADs), a group of post-translational enzymes, catalyze the conversion of protein-bound arginine residues to citrulline residues in a calcium ion-dependent manner and are widely distributed in various organs of vertebrates. Although the existence of four isoforms of PAD (types I, II, III, and IV) is reported in rodents, the relative functions of the isoforms with respect to their colocation in the tissues have yet to be explored. In this study, we cloned the full-length cDNA encoding mouse PAD type I by screening a uterine cDNA library and using the RACE method. This cDNA consists of an open reading frame of 1989 bases encoding 662 amino acids (73,823 Da), a 5'-untranslated region of 127 bases and a 3'-untranslated region of 1639 bases. Comparative reverse transcription-PCR and Northern-blot analyses detected PAD type I mRNA only in the epidermis and uterus. Administration of estrogen to adult ovariectomized mice increased the content of PAD type I mRNA in the uterus, providing evidence that its expression is under the control of the sex steroid hormone. We also cloned the full-length cDNAs of mouse PAD type III and type IV by the reverse transcription-PCR and RACE methods. The primary structure of PAD type III contains 664 amino acids (75,098 Da) deduced from the coding region of 1995 bases, and the primary structure of PAD type IV consists of 666 amino acids (74,475 Da) deduced from the coding region of 2001 bases. Comparison of the deduced amino acid sequences of all four isoforms of PAD showed about 50% identity with each other, the 3' regions being highly homologous compared with the 5' regions.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10092850     DOI: 10.1046/j.1432-1327.1999.00083.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  16 in total

Review 1.  Protein Arginine Deiminases and Associated Citrullination: Physiological Functions and Diseases Associated with Dysregulation.

Authors:  Erin E Witalison; Paul R Thompson; Lorne J Hofseth
Journal:  Curr Drug Targets       Date:  2015       Impact factor: 3.465

2.  cDNA cloning, gene organization and expression analysis of human peptidylarginine deiminase type I.

Authors:  Marina Guerrin; Akihito Ishigami; Marie-Claire Méchin; Rachida Nachat; Séverine Valmary; Mireille Sebbag; Michel Simon; Tatsuo Senshu; Guy Serre
Journal:  Biochem J       Date:  2003-02-15       Impact factor: 3.857

3.  Citrullination regulates the expression of insulin-like growth factor-binding protein 1 (IGFBP1) in ovine uterine luminal epithelial cells.

Authors:  Coleman H Young; Heather M Rothfuss; Philip F Gard; Aaron Muth; Paul R Thompson; Ryan L Ashley; Brian D Cherrington
Journal:  Reproduction       Date:  2016-10-10       Impact factor: 3.906

4.  Substrate specificity and kinetic studies of PADs 1, 3, and 4 identify potent and selective inhibitors of protein arginine deiminase 3.

Authors:  Bryan Knuckley; Corey P Causey; Justin E Jones; Monica Bhatia; Christina J Dreyton; Tanesha C Osborne; Hidenari Takahara; Paul R Thompson
Journal:  Biochemistry       Date:  2010-06-15       Impact factor: 3.162

5.  A family based study shows no association between rheumatoid arthritis and the PADI4 gene in a white French population.

Authors:  L Caponi; E Petit-Teixeira; M Sebbag; F Bongiorni; S Moscato; F Pratesi; C Pierlot; J Osorio; S Chapuy-Regaud; M Guerrin; F Cornelis; G Serre; P Migliorini
Journal:  Ann Rheum Dis       Date:  2004-10-14       Impact factor: 19.103

Review 6.  Methods for the detection of peptidylarginine deiminase (PAD) activity and protein citrullination.

Authors:  Sanne M M Hensen; Ger J M Pruijn
Journal:  Mol Cell Proteomics       Date:  2013-12-02       Impact factor: 5.911

7.  Peptidylarginine deiminase gene is differentially expressed in freshwater and brackish water rainbow trout.

Authors:  Alexander Rebl; Bernd Köllner; Eckhard Anders; Klaus Wimmers; Tom Goldammer
Journal:  Mol Biol Rep       Date:  2009-08-20       Impact factor: 2.316

8.  Peptidylarginine deiminase 2 (PAD2) overexpression in transgenic mice leads to myelin loss in the central nervous system.

Authors:  Abdiwahab A Musse; Zhen Li; Cameron A Ackerley; Dorothee Bienzle; Helena Lei; Roberto Poma; George Harauz; Mario A Moscarello; Fabrizio G Mastronardi
Journal:  Dis Model Mech       Date:  2008-11-06       Impact factor: 5.758

Review 9.  Peptidylarginine deiminases in citrullination, gene regulation, health and pathogenesis.

Authors:  Shu Wang; Yanming Wang
Journal:  Biochim Biophys Acta       Date:  2013-07-13

10.  Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages.

Authors:  E R Vossenaar; T R D Radstake; A van der Heijden; M A M van Mansum; C Dieteren; D-J de Rooij; P Barrera; A J W Zendman; W J van Venrooij
Journal:  Ann Rheum Dis       Date:  2004-04       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.